Sio Gene Therapies
SIOX
$0.48
Share price
0.00%
Change (1 day)
16.59%
Change (1 year)
Sio Gene Therapies (SIOX) - P/B ratio
P/B ratio as of May 2024 : 0.7837
According to Sio Gene Therapies's latest financial reports the company has a price-to-book ratio of 0.7837.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sio Gene Therapies - P/B ratio (from 2015 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 0.7132 | -42.79% |
| 2021-12-31 | 1.25 | -29.47% |
| 2020-12-31 | 1.77 | -92.36% |
| 2019-12-31 | 23.1 | 239.72% |
| 2018-12-31 | 6.81 | 27.87% |
| 2017-12-31 | 5.32 | -28.06% |
| 2016-12-31 | 7.40 | 19.19% |
| 2015-12-31 | 6.21 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -16.77% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | 149.95% | 🇺🇸 USA |